Eli Lilly (LLY) Stock Forecast & Analysis 2026
Stock Price Forecast & Analysis Tables
| Forecast Scenario |
Projected Price (USD) |
| Base Case (Most Likely) |
$1,450 - $1,650 |
| Bull Case (Optimistic) |
$1,800+ |
| Bear Case (Pessimistic) |
$1,100 - $1,200 |
| Target Level |
Price Target (USD) |
| Target 1 |
$1,350 |
| Target 2 |
$1,500 |
| Target 3 |
$1,650 |
| Target 4 |
$1,800 |
| Target 5 |
$2,000 |
| Support Level |
Price Target (USD) |
| Support 1 |
$780 |
| Support 2 |
$720 |
| Support 3 |
$680 |
| Support 4 |
$625 |
| Support 5 |
$580 |
| Term |
Target 1 |
Target 2 |
Short Term
(1-6 Months) |
$880 |
$920 |
Medium Term
(6-18 Months) |
$1,100 |
$1,250 |
Long Term
(By 2026) |
$1,450 |
$1,600 |
| Resistance Levels (USD) |
Support Levels (USD) |
| $935 (52-wk High) |
$812 (Recent Low) |
| $980 |
$780 |
| $1,050 |
$720 |
| $1,100 |
$680 |
| $1,200 |
$625 (52-wk Low) |
| Strong Buy Zone (USD) |
| Above $940 |
| Above $980 with high volume |
| Above $1,050 |
| Above $1,100 |
| Above $1,200 (confirms strong bull trend) |
| Strong Sell / Caution Zone (USD) |
| Below $780 |
| Below $720 |
| Below $680 |
| Below $625 |
| Below $600 |
| Profit Booking Zone (USD) |
Aggressiveness |
| $1,350 - $1,450 |
Moderate |
| $1,500 - $1,600 |
High |
| $1,700 - $1,800 |
Very High |
| $1,900+ |
Extreme (Consider full exit) |
| Breakout Level (USD) |
Significance |
| $935 |
Break above all-time high |
| $980 |
Confirms bullish momentum |
| $1,050 |
Opens path to much higher targets |
| $1,100 |
Major psychological and technical level |
| $1,200 |
Mega Bull market confirmation |
| Breakdown Level (USD) |
Significance |
| $780 |
Breaks key short-term support |
| $720 |
Indicates a deeper correction |
| $680 |
Breaks major moving averages |
| $625 |
Breaks 52-week low, very bearish |
| $600 |
Enters a long-term bear market |
| Financial Indicator |
Projected for 2026 |
| Revenue |
$68 - $72 Billion |
| Net Income |
$16 - $18 Billion |
| Earnings Per Share (EPS) |
$19.50 - $21.50 |
| P/E Ratio |
70 - 80 |
| Net Profit Margin |
~25% |
Multibagger Potential Analysis
From the current price of ~$844, a multibagger (2x) would require the stock to reach ~$1,688. Our base case forecast of $1,450 - $1,650 places it at the cusp of being a double (approx. 2x) from current levels. While it is a highly ambitious target, given the company's stellar growth in its key drug segments (Mounjaro, Zepbound), it is not entirely out of the realm of possibility. It has the potential to be a near-multibagger by 2026.
Pro Tips for Traders & Investors
Short-Term Traders
Focus on the range between $780 (support) and $935 (resistance). Buy near support with a stop loss and target the resistance. A confirmed breakout above $935 can be chased for targets of $980 and $1,050.
Medium-Term Investors
Accumulate the stock on any dips towards the $720-$780 support zone. Your core targets should be in the $1,400 - $1,700 range over the next 12-18 months.
Long-Term Investors
View any significant market correction as a buying opportunity. The long-term story remains strong. Hold with a trailing stop loss and review the position only if the fundamental story changes.
Frequently Asked Questions (FAQs)
Can Eli Lilly (LLY) stock become a multibagger in 2026?
Based on our analysis, Eli Lilly has the potential to be a near-multibagger. From its current price, reaching a 2x target (~$1,688) is ambitious but falls within our bullish forecast range, driven by strong financial performance and high demand for its key products.
What are the short-term price targets for LLY stock?
Our short-term (1-6 months) price targets for Eli Lilly are $880, $920, $950, $1,000, and $1,050, depending on market momentum and breakout above key resistance levels.
What are the medium-term targets for LLY stock?
For a medium-term horizon (6-18 months), we project LLY could reach between $1,100 and $1,700, based on its earnings growth trajectory and market expansion.
What are the long-term price targets for LLY stock by 2026?
Our long-term forecast for Eli Lilly by the year 2026 projects a price range of $1,450 to $2,100, with a base case of $1,450-$1,650.
At what price should investors buy Eli Lilly stock?
Investors can consider buying LLY stock on dips towards key support levels, such as $780, $720, and $680. For those looking for a breakout confirmation, a buy trigger exists above $935.
Disclaimer: The price targets and financial projections presented in this analysis are solely based on current financial data, technical indicators, and prevailing market conditions. These situations can change anytime, and the company's financial position will also change anytime. This analysis is for informational and educational purposes only and does not constitute a "buy," "sell," or "hold" recommendation. Investors and traders are strongly advised to conduct their own independent research, consult with a qualified financial advisor, and regularly check their investments, trades, and the company's ongoing financial performance and news. Past performance is not an indicator of future results.
Piyush Sharma
Qualifications: MBA (India), MBA (Australia), Master of Professional Accounting (Australia).
18+ years in the Indian stock market and running this website for 15+ years. Founder of PS International Group and Hamarijeet.com — popular for study-visa guidance, career help, government schemes, jobs and digital product updates.
Please do not enter any spam link in the comment box.